This company listing is no longer active
Generex Biotechnology Management
Management criteria checks 2/4
Key information
Joe Moscato
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.4yrs |
| CEO ownership | 0.4% |
| Management average tenure | 5.4yrs |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Apr 30 2021 | n/a | n/a | -US$37m |
| Jan 31 2021 | n/a | n/a | -US$52m |
| Oct 31 2020 | n/a | n/a | -US$35m |
| Jul 31 2020 | US$623k | US$623k | -US$33m |
| Apr 30 2020 | n/a | n/a | -US$26m |
| Jan 31 2020 | n/a | n/a | -US$31m |
| Oct 31 2019 | n/a | n/a | -US$36m |
| Jul 31 2019 | US$103k | n/a | -US$9m |
| Apr 30 2019 | n/a | n/a | US$10m |
| Jan 31 2019 | n/a | n/a | US$24m |
| Oct 31 2018 | n/a | n/a | US$27m |
| Jul 31 2018 | US$100k | n/a | US$36m |
| Apr 30 2018 | n/a | n/a | US$9m |
| Jan 31 2018 | n/a | n/a | -US$37m |
| Oct 31 2017 | n/a | n/a | -US$43m |
| Jul 31 2017 | US$50k | n/a | -US$70m |
Compensation vs Market: Insufficient data to establish whether Joe's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.
CEO
Joe Moscato (57 yo)
5.4yrs
Tenure
US$623,082
Compensation
Mr. Joseph Moscato, also known as Joe, serves as Chief Executive Officer and Vice-Chairman of the Board at NuGenerex Immuno-Oncology, Inc. and served as its Chairman of the Board. Mr. Moscato has been the...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| CFO & Treasurer | 5.4yrs | US$10.00k | 0% $ 0 | |
| Chief Operating Officer | 4.4yrs | US$566.44k | 0% $ 0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Chief Legal Officer & Chief Administrative Officer | 2.8yrs | US$424.83k | 0% $ 0 | |
| Chief Commercial Officer | 3.4yrs | no data | 1.08% $ 658.9 | |
| Chief Scientific Officer & Chief Medical Officer | 5.4yrs | no data | 0% $ 0 | |
| Chief Marketing Officer | 3.6yrs | no data | no data | |
| Executive Vice President of Research & Drug Development | 5.4yrs | US$68.33k | 0% $ 0 |
5.4yrs
Average Tenure
56.5yo
Average Age
Experienced Management: GNBT's management team is seasoned and experienced (5.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Chairman of the Board | 5.4yrs | US$623.08k | 0.36% $ 219.0 | |
| Chief Investment Officer & Director | 5.4yrs | US$18.88k | 0% $ 0 | |
| Independent Director | 18.3yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 5.4yrs | US$18.88k | 0.26% $ 160.2 | |
| Independent Director & Member of Scientific Advisory Board | 11.8yrs | US$47.20k | 0% $ 0 | |
| Independent Director | 11yrs | US$118.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Independent Director | 3.2yrs | no data | 0% $ 0 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data |
5.4yrs
Average Tenure
59yo
Average Age
Experienced Board: GNBT's board of directors are considered experienced (5.4 years average tenure).